GLOO:NASDAQGloo Holdings, Inc. Analysis
Data as of 2026-05-19 - not real-time
$5.00
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Gloo Holdings (GLOO) is trading at $5, well under its 20‑day SMA of $6.53, 50‑day SMA of $6.10 and 200‑day SMA of $6.34, with a bearish MACD and an RSI of 33.6 indicating oversold conditions. Despite the technical softness, the stock carries a forward P/E of 55.6, markedly higher than the software‑application industry average of 38, and a price‑to‑book of nearly 3×, suggesting it is currently overvalued relative to earnings expectations. High 30‑day volatility (≈120%) and a decreasing volume trend add to the short‑term uncertainty, while a beta of 0.79 points to lower systematic risk.
Fundamentally, GLOO reports modest revenue growth (~4%) but deep losses (operating margin –105%, profit margin –166%) and negative cash flows, offset by a net cash position of $13M after debt. The recent acquisition of EnterpriseMarketdesk (EMD) adds AI‑enabled Workday services, offering a potential growth catalyst and a forward EPS of $0.09, yet the turnaround risk remains high.
Fundamentally, GLOO reports modest revenue growth (~4%) but deep losses (operating margin –105%, profit margin –166%) and negative cash flows, offset by a net cash position of $13M after debt. The recent acquisition of EnterpriseMarketdesk (EMD) adds AI‑enabled Workday services, offering a potential growth catalyst and a forward EPS of $0.09, yet the turnaround risk remains high.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- Price below all major moving averages and bearish MACD
- High forward P/E relative to industry
- Decreasing volume and elevated short‑term volatility
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Potential revenue lift from the EMD acquisition
- Positive forward EPS outlook despite current losses
- Net cash cushion mitigating near‑term liquidity concerns
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Niche focus on faith‑based organizations could sustain a differentiated market
- Long‑run profitability hinges on successful integration of AI‑enabled services
- Current valuation may compress if turnaround materializes
Key Metrics & Analysis
Financial Health
Revenue Growth417.70%
Profit Margin-165.99%
P/E Ratio55.6
ROE-185.03%
ROA-35.17%
Debt/Equity28.09
P/B Ratio3.0
Op. Cash Flow$-80499000
Free Cash Flow$-50239752
Industry P/E38.0
Technical Analysis
TrendNeutral
RSI33.6
Support$4.99
Resistance$7.95
MA 20$6.53
MA 50$6.10
MA 200$6.34
MACDBearish
VolumeDecreasing
Fear & Greed Index89.18
Valuation
Target Price$13.00
Upside/Downside160.00%
GradeOvervalued
TypeBlend
Risk Assessment
Beta0.79
Volatility119.95%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.